• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches   1990-1999  
Title Created Date
Novel endocrine therapies in breast cancer 15 September 2013
Characterization of a new malignant human T-cell line (PFI-285) sensitive to ascorbic acid 12 September 2013
Ascorbic acid in the prevention and treatment of cancer - Kathleen A. Head 10 September 2013
Changes in numbers of prolactin receptors during the cell cycle of Nb2 cells 01 September 2013
Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors 30 August 2013
Somatostatin inhibits PDGF-stimulated Ras activation in human neuroblastoma cells 27 August 2013
Somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinoma cell lines 27 August 2013
Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1 26 August 2013
Epidermal growth factor receptor, somatostatin and bcl-2 in human pancreatic tumor xenografts. An immunohistochemical study 23 August 2013
Activation of three distinct RXR/RAR heterodimers induces growth arrest and differentiation of neuroblastoma cells 19 August 2013
Display # 

Page 56 of 60

  • Start
  • Prev
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • Next
  • End

Search

Follow us...

Latest

  • The antiproliferative effects of somatostatin receptor subtype 2 in breast cancer cells
  • Somatostatin and the treatment of cancer
  • Somatostatin and analogues in the treatment of cancer. A review
  • A retrospective observational study on cases of osteosarcomas treated with a multitherapy: The rationale and effectiveness
  • Somatostatin in oncology, the overlooked evidences
  • The Di Bella Method (DBM) in the treatment of prostate cancer: a preliminary retrospective study of 16 patients and a review of the literature
  • Melatonin induces apoptosis in human neuroblastoma cancer cells
  • Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells
  • Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions
  • Consequences of lethal-whole-body gamma radiation and possible ameliorative role of melatonin
  • Antiproliferative activity of melatonin by transcriptional inhibition of cyclin D1 expression: a molecular basis for melatonin-induced oncostatic effects
  • Complete objective response of oesophageal squamocellular carcinoma to biological treatment
  • The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 55 cases of lymphomas
  • Can Melatonin Help Us in Radiation Oncology Treatments?
  • A radiobiological review on melatonin: a novel radioprotector
  • Immunomodulatory effect of melatonin in SK-LU-1 human lung adenocarcinoma cells co-cultured with peripheral blood mononuclear cells
  • Mechanisms Underlying Tumor Suppressive Properties of Melatonin
  • Melatonin induces apoptosis through a caspase-dependent but reactive oxygen species-independent mechanism in human leukemia Molt-3 cells

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • How effective is chemo therapy?
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer